Kerry Ross, MD
Internal Medicine · Dickson, TNNPI 1932102670
Payments from drug & device makers
Across 1,068 payments — averaging $16.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- Lilly USA, LLC$1K
- AstraZeneca$1K
- Amgen$1K
- Pfizer$1K
- Boehringer Ingelheim$1K
- plus $9K from 51 others
What the payments were for
- Food & beverage$17,215100%
- Education$500%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$17,265 in reported general payments places this provider in the 95th percentile of 2,216 internal medicine providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 119 | $138,361 |
| JardianceEmpagliflozin | 97 | $103,210 |
| EliquisApixaban | 125 | $100,058 |
| MounjaroTirzepatide | 73 | $97,800 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 94 | $82,072 |
| FarxigaDapagliflozin Propanediol | 68 | $67,505 |
| TrulicityDulaglutide | 33 | $62,598 |
| XareltoRivaroxaban | 75 | $60,913 |
| LinzessLinaclotide | 76 | $50,317 |
| Tresiba Flextouch U-200Insulin Degludec | 26 | $42,263 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 53 | $38,390 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $34,736 |
| KerendiaFinerenone | 39 | $31,395 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 23 | $26,577 |
| JanuviaSitagliptin Phosphate | 21 | $21,736 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $1,446 | $160,398106 claims |
| Novo NordiskOzempic | $2,181 | $138,361119 claims |
| Boehringer IngelheimJardiance, Stiolto Respimat, Tradjenta, Spiriva Respimat | $1,059 | $129,680133 claims |
| PfizerEliquis | $1,175 | $100,058125 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $430 | $82,07294 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $643 | $80,825111 claims |
| AstraZenecaFarxiga | $1,414 | $67,50568 claims |
| Johnson & JohnsonXarelto | $520 | $60,91375 claims |
| AbbVieLinzess | $1,014 | $50,31776 claims |
| BayerKerendia | $721 | $31,39539 claims |
| MerckJanuvia | $379 | $21,73621 claims |
| Astellas Pharma US IncMyrbetriq | $77 | $12,34717 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,216 internal medicine providers in Tennessee.
Other internal medicine in Dickson
- Mark McKenzieChattanooga$11.9M
- Bernard GrunstraBristol$6.4M
- Jewel WhiteKingsport$5.7M
- Judith WhiteKingsport$5.6M
- Obadias MarquezOoltewah$2.8M
- Amanda Moore MillerKnoxville$2.3M
- Rick WhilesBristol$1.5M
- John AndersonNashville$1.5M
- David MorinKingsport$1.4M
- John KirbyJefferson City$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.